GlaxoSmithKline group of companies ,   Unknown

Antibiotic - penicillin semisynthetic + beta-lactamase inhibitor.

Tablets, film-coated 500 mg + 125 mg.

Antibiotic - penicillin semisynthetic + beta-lactamase inhibitor

Powder for the preparation of a solution for intravenous administration, 1000 mg + 200 mg.

Antibiotic - penicillin semisynthetic + beta-lactamase inhibitor
Powder for oral suspension, 125 mg / 31.25 mg in 5 ml, 200 mg / 28.5 mg in 5 ml, 400 mg / 57 mg in 5 ml.
Antibiotic - penicillin semisynthetic + beta-lactamase inhibitor

Film-coated tablets (250 mg amoxicillin, 125 mg clavulanic acid).

Antibiotic - penicillin semisynthetic + beta-lactamase inhibitor

Tablets coated with a film coating of 875 mg / 125 mg.

Antibiotic - penicillin semisynthetic + beta-lactamase inhibitor

Powder for the preparation of a suspension for oral administration.

Antibiotic - penicillin semisynthetic + beta-lactamase inhibitor
Powder for suspension for oral administration, 600 mg + 42.9 mg / 5 ml.
Antibiotic, penicillin semisynthetic + beta-lactamase inhibitor

Tablets with modified release, film-coated, 1000 mg + 62.5 mg.

Immunosuppressive drugs

Lyophilizate for the preparation of concentrate for the preparation of a solution for infusions, 120 mg, 400 mg.

MIBP vaccine
Lyophilizate for the preparation of a solution for subcutaneous administration, 1 dose (0.5 ml).
The iron preparation

Dragee, 325 mg.

Glucocorticosteroid for topical application

Cream for external use, 0.05%.

Antifungal agent.

Cream for external use 1%.

For 20 grams in an aluminum tube, coated internally with a varnish sealed with a membrane, sealed with a screwed polyethylene or polypropylene cap. One tube with instructions for medical use is placed in a cardboard box.

Antifungal agent.

Vaginal tablets, 100 mg.

For 6 tablets in a PVC / aluminum foil blister. One blister with instructions for medical use is placed in a cardboard box.

Means to eliminate acute respiratory symptoms and "cold" (non-narcotic analgesic agent + and - adrenoagonists + vitamin).
Powder for solution for oral administration, 6 g. Each
Nondepolarizing muscle relaxant of peripheral action.

Solution for intravenous administration, 2 mg / ml.

MIBP - globulin

Solution for infusion, 100 mg / ml.

Bronchodilator combined (beta2-adrenomimetic selective + glucocorticosteroid local).

Powder for inhalation dosed, 22 mcg + 92 mcg / dose, 22 mcg + 184 mcg / dose.

H-1 histamine receptor antagonist
Capsules 8 mg.
Antitumor agent, protein kinase inhibitor.

Capsules 50 mg, 75 mg.

Antibiotic-penicillin semisynthetic + beta-lactamase inhibitor

Lyophilizate for the preparation of a solution of 1.5 g +100 mg or 3.0 g + 200 mg.

Nondepolarizing muscle relaxant of peripheral action.
Solution for intravenous administration 10 mg / ml.